Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE risk categories.

[1]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[2]  Michael E. Miller,et al.  Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .

[3]  Dirk De Bacquer,et al.  EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[4]  I. Ockene,et al.  Varenicline for smoking cessation in patients with coronary heart disease. , 2010, Circulation.

[5]  K. Kotseva,et al.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[6]  A. Ahlbom,et al.  Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP) , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[7]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary. , 2007, Atherosclerosis.

[8]  A. Baburin,et al.  The association between hyperglycaemia on admission and 180‐day mortality in acute myocardial infarction patients with and without diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[9]  G. De Backer,et al.  Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[10]  B. Psaty,et al.  Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. , 2002, Journal of clinical epidemiology.

[11]  E Geraci,et al.  Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. , 2001, European heart journal.

[12]  L. Wilhelmsen,et al.  Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. , 2001, European heart journal.

[13]  R B D'Agostino,et al.  Primary and subsequent coronary risk appraisal: new results from the Framingham study. , 2000, American heart journal.

[14]  L. Coupal,et al.  Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. , 1998, Archives of internal medicine.

[15]  David Machin,et al.  Survival Analysis: A Practical Approach , 1995 .

[16]  R. Mulcahy,et al.  Factors influenceing long-term prognosis in male patients surviving a first coronary attack. , 1975, British heart journal.

[17]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[18]  A. Hoes,et al.  Euroaction preventive cardiology programme plus intensive smoking cessation with varenicline , 2012 .

[19]  J. Critchley,et al.  Smoking cessation for the secondary prevention of coronary heart disease. , 2003, The Cochrane database of systematic reviews.

[20]  David R. Wood,et al.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. , 2001, European heart journal.

[21]  Philippe Amouyel,et al.  A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. , 1997 .